Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
eNq1mE1v2kAQhu/8CsuH3rDNN2kNUUuTFilRKQG16gWt7SEsNbvOfhCSX981hoZUa4UurMQBvPY745nxsy8OLzer1FkD45iSnlvzAtcBEtMEk/ueO51cV7vuZb8SLtEaHZzW8QKvVnedOEWc99x81YsAEe79vL35DOp6YG6/4oQ0WkIsXp0nBU69r4gvblGWn+OEa4oTZwViQZOem0mxPeqEXDCVRf+Rst88QzGE/u7I4epy1jw8Hvq52BGqkgO7QeReKwrESDOWjAERAyTgnrInrfQ8ntW7nXYQdI1CYD4GTiWLYYTEYsToGieQ6COhlINRkPljcgdsnYLIg2jF/WW84kbiaIk2Y3gY6pP+qFYHYiOqQbXW6bQbjUa70Wy1AqNQ7KBU+uFRN+FnMxWlrj4+EB+vIibXOEZVrL4ITHBk2KcRZQKlljqE+eD1rFmKw+DhzUlIMM9S9OQteWZaKsSQWgamiGDvRvI7mDDFqFTV7B99ItPU/8+spzuCWMo4B9SASiJKQHI9Ni3EgBIBm/KOmrFPbHaziIGfT/aZEj33RzJKcWyKNwUgCVxMx8NyutkCwyfEYcrskeEHJgl95OcnzmGHLWWfbaGpFc1YUpvVL7rtWqtl/ED9UuNUsvNcSUYz8BWLMD8FMUMyp6fCRU2oXmo/n1ZGc2uJaIxSKDFFVUPmqJncezhrU2/viSoWtKJfriamo/JdAnu62/7USuOk97fJZkC2QXk1mG8lXjzCefJBq3vRaL5Dq+zD3m33DJ11IXqEsW52DcslmR47CyEy/t73F4hXOVIl9ebsuO3hUluJc1RDsfilufb+A1jxCYVvKjhsKfWo2GCPb6fpM/yWizjVGe+u3zlwbQzBJJzQhwL31qA8vDo/519ssbW0R69oYy/M1sIigSmxZadkpGf0STuL6iu5ZgoO3+ZzXPJapnQuQ794JdSvhH7+Oqhf+QPWdhOq
8D8AAxpWeAZZBYNe
